ChromaDex (NASDAQ:CDXC) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of ChromaDex (NASDAQ:CDXC – Free Report) in a research note released on Saturday morning. The brokerage issued a buy rating on the stock. A number of other brokerages have also commented on CDXC. HC Wainwright reissued a “buy” rating and issued a $11.00 price target on shares of ChromaDex in […]
More Stories
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Acquired by Ameriprise Financial Inc.
Ameriprise Financial Inc. lifted its position in Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 3.7% in the 4th...
Algert Global LLC Acquires New Position in Inseego Corp. (NASDAQ:INSG)
Algert Global LLC acquired a new position in shares of Inseego Corp. (NASDAQ:INSG – Free Report) during the 4th quarter,...
Ameriprise Financial Inc. Increases Position in The Toro Company (NYSE:TTC)
Ameriprise Financial Inc. boosted its holdings in The Toro Company (NYSE:TTC – Free Report) by 172.9% in the fourth quarter,...
Ameriprise Financial Inc. Sells 22,808 Shares of Equifax Inc. (NYSE:EFX)
Ameriprise Financial Inc. reduced its stake in shares of Equifax Inc. (NYSE:EFX – Free Report) by 16.4% during the 4th...
Ameriprise Financial Inc. Lowers Holdings in Clear Secure, Inc. (NYSE:YOU)
Ameriprise Financial Inc. reduced its stake in shares of Clear Secure, Inc. (NYSE:YOU – Free Report) by 11.8% during the...
Ameriprise Financial Inc. Purchases 13,501 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)
Ameriprise Financial Inc. raised its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 4.2% in the 4th quarter,...